Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017

C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011

C Hiemke, P Baumann, N Bergemann… - …, 2011 - thieme-connect.com
Therapeutic drug monitoring (TDM), ie, the quantification of serum or plasma concentrations
of medications for dose optimization, has proven a valuable tool for the patient-matched …

Potentially harmful drug–drug interactions in the elderly: a review

LE Hines, JE Murphy - The American journal of geriatric pharmacotherapy, 2011 - Elsevier
BACKGROUND: Elderly patients are vulnerable to drug interactions because of age-related
physiologic changes, an increased risk for disease associated with aging, and the …

Lithium during pregnancy and after delivery: a review

EMP Poels, HH Bijma, M Galbally, V Bergink - International journal of …, 2018 - Springer
Lithium is an effective treatment in pregnancy and postpartum for the prevention of relapse
in bipolar disorder. However, lithium has also been associated with risks during pregnancy …

Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders

CT Chiu, DM Chuang - Pharmacology & therapeutics, 2010 - Elsevier
Lithium has been used clinically to treat bipolar disorder for over half a century, and remains
a fundamental pharmacological therapy for patients with this illness. Although lithium's …

The science and practice of lithium therapy

GS Malhi, M Tanious, P Das… - Australian & New …, 2012 - journals.sagepub.com
Introduction: Despite more that 60 years of clinical experience, the effective use of lithium for
the treatment of mood disorder, in particular bipolarity, is in danger of becoming obsolete. In …

Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety

EM Grandjean, JM Aubry - CNS drugs, 2009 - Springer
Lithium use in mental diseases has changed over the years but remains a cornerstone of
treatment in bipolar disorders. In two companion papers, we have reviewed existing (and …

Lithium rescues synaptic plasticity and memory in Down syndrome mice

A Contestabile, B Greco, D Ghezzi… - The Journal of …, 2012 - Am Soc Clin Investig
Down syndrome (DS) patients exhibit abnormalities of hippocampal-dependent explicit
memory, a feature that is replicated in relevant mouse models of the disease. Adult …

Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring

KM Deligiannidis, N Byatt… - Journal of clinical …, 2014 - journals.lww.com
Objective Pharmacotherapy for mood disorders during pregnancy is often complicated by
pregnancy-related pharmacokinetic changes and the need for dose adjustments. The …

Role of lithium augmentation in the management of major depressive disorder

M Bauer, M Adli, R Ricken, E Severus, M Pilhatsch - CNS drugs, 2014 - Springer
The high rate of non-responders to initial treatment with antidepressants requires
subsequent treatment strategies such as augmentation of antidepressants. Clinical …